Rybelsus from Novo Nordisk is officially the first oral GLP-1 drug approved for this indication. The FDA's decision was based on the SOUL trial, which included data from more than 9,000 patients with type 2 diabetes.

U.S. District Court Judge Susan Illston said the firings appear to be politically motivated and may exceed the authority of the executive branch. She sided against the Trump administration, issuing a temporary restraining order to stop 4,200 federal employees from being fired. 

PET has already gained significant momentum in recent years. Now, researchers are pointing to another possible use for the popular imaging modality: assessing carotid artery atherosclerosis.